General Dermatology

This review of the latest dermatologic studies includes a review on JAK-induced acne, a case series of atypical pediatric-onset Behçet's Disease, research on drug survival in AD, and more.

Dermatology Times highlights 2025's innovations in dermatology, featuring new therapies, expert insights, and a look ahead to 2026 advancements.

John Barbieri, MD, MBA, outlines how missing reviewer identification, unclear step-therapy requirements, and limited engagement during appeals contribute to delays, inefficiencies, and potential clinical harm for patients.

PolarityBio advances SkinTE for diabetic foot ulcers, aiming for a breakthrough in chronic wound treatment with promising trial results announced soon.

Discover how hotel shampoos, conditioners, and body washes contribute to allergic contact dermatitis, revealing significant regional differences in allergen prevalence.

Explore the top headlines of the week, including insights on the latest clinical trials, therapeutic updates, and more.

In case you missed it, this week we had news about clascoterone 5% for hair growth improvements, dermatology's role in lung cancer toxicities, IPV in female psoriasis patients, and more.

This week, we feature top articles from our sister publications on regulatory updates, clinical trial insights, and more.

Selected pieces will be featured in Dermatology Times’ year-end and early-2026 coverage.

Discover how a proprietary extract from saw palmetto promotes hair growth and reduces thinning in adults, offering a safe alternative to traditional treatments.

The study provides new evidence beyond previously established associations with breast, ovarian, and uterine cancers.

This review of the latest dermatologic studies includes a new instrument to measure QoL in pediatric alopecia, BTX-A in patients with recessive dystrophic epidermolysis bullosa, eosinophilic pustular folliculitis in children, and more.

Citius Oncology’s IL-2 receptor–directed fusion protein offers rapid responses and pruritus improvement for relapsed or refractory stage I–III CTCL.

Support vital dermatology organizations this Giving Tuesday and beyond to enhance patient care, drive research, and foster community.

Patrick Burnett, MD, PhD, of Arcutis, explores new treatments for vitiligo and hidradenitis suppurativa, while advancing systemic biologics for atopic dermatitis by 2026.

Explore the top headlines of the week, including insights on the latest clinical trials, therapeutic updates, and more.

In case you missed it, this week we had news about LNK01004's phase 2 AD results, INF904's efficacy in HS and CSU, new data supporting tralokinumab for hand AD, and more.

This week, we feature top articles from our sister publications on regulatory updates, clinical trial insights, and more.

Explore the top headlines of the month, including insights on regulatory updates, expert pearls, and more.

Dermatology Times is looking back on the top stories in dermatology from the month of November.

Hair growth, density, and aging patterns differ across populations, influencing the presentation and management of hair disorders like alopecia areata.

Learn more about the in-depth topics covered in the November 2025 print issue of Dermatology Times.

Dermatology Times is recapping our exclusive expert interviews from the month of November.